Side effects of drugs annual. a worldwide yearly survey of new data in adverse drug reactions / Volume 40 :

Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Volume 40, first published in 1977, and continually published as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs, presents clinicians and medical investigators with a rel...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Ray, Sidhartha D. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Amsterdam, Netherlands : Elsevier, [2�018]
Edición:First edition.
Colección:Side Effects of Drugs Annual ; Volume 40
Temas:
Drugs > Side effects.
Drug-Related Side Effects and Adverse Reactions
M�edicaments > Effets secondaires.
MEDICAL > Pharmacology.
Drugs > Side effects
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 SCIDIR_on1061860981
003 OCoLC
005 20231120010324.0
006 m o d
007 cr cnu---unuuu
008 181108t20182018ne o 001 0 eng d
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d GZM  |d UKMGB  |d YDX  |d OCLCQ  |d OPELS  |d UKAHL  |d SFB  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO 
016 7 |a 019087214  |2 Uk 
019 |a 1064453127 
020 |a 9780444641205  |q (electronic bk.) 
020 |a 0444641203  |q (electronic bk.) 
020 |z 9780444641199 
020 |z 044464119X 
035 |a (OCoLC)1061860981  |z (OCoLC)1064453127 
050 4 |a RM302.5 
072 7 |a MED  |x 071000  |2 bisacsh 
082 0 4 |a 615.7/042  |2 23 
245 0 0 |a Side effects of drugs annual.  |n Volume 40 :  |b a worldwide yearly survey of new data in adverse drug reactions /  |c edited by Sidhartha D. Ray. 
250 |a First edition. 
264 1 |a Amsterdam, Netherlands :  |b Elsevier,  |c [2�018] 
264 4 |c �2018 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 0 |a Side Effects of Drugs Annual ;  |v Volume 40 
500 |a Includes indexes. 
520 |a Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Volume 40, first published in 1977, and continually published as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs, presents clinicians and medical investigators with a reliable and critical survey of new data and trends in the area of adverse drug reactions and interactions, with an international team of specialists contributing each year. Topics covered in this release include Central Nervous System Stimulants and Drugs that Suppress Appetite, Antidepressant drugs, Lithium, Drugs of abuse, Hypnotics and sedatives, Antipsychotic Drugs, and much more. 
588 0 |a Print version record. 
505 0 |a Front Cover -- Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions -- Copyright -- Contributors -- Contents -- Preface -- Special Reviews in SEDA 40 -- Table of Essays, Annuals 1-39 -- Abbreviations -- ADRs, ADEs and SEDs: A Bird's Eye View -- Introduction -- Analysis of ADEs, ADRs, Side Effects and Toxicity -- Terminology -- EIDOS -- DoTS -- WHO Classification -- References on Adverse Drug Reactions -- Further Reading -- Pharmacogenomics Considerations -- Enzymes and Transporters -- Human Leukocyte Antigens (HLA) -- Genetic Testing Technology -- Conclusion -- References -- Further Reading -- Immunological Reactions -- Type I Reactions (IgE-Mediated Anaphylaxis -- Immediate Hypersensitivity) -- Type II Reactions (Cytotoxic Reactions) -- Type III Reactions (Immune Complex Reactions) -- Type IV Reactions (Cell-Mediated or Delayed Hypersensitivity Reactions) -- Other Types of Reactions -- References -- Further Reading -- Analysis of Toxicological Reactions -- Potentiation Reactions -- Examples -- Synergistic Effect -- Additive Effect -- Examples -- Antagonistic Effects -- Examples -- Cross References -- Grades of Adverse Drug Reactions -- References -- FDA Pregnancy Categories/Classification of Teratogenicity -- Category A -- Category B -- Category C -- Category D -- Category X -- Category N -- References -- Clinicians are suggested to be aware of the information contained in the following literature originating from regulatory agen -- Conclusion -- Chapter 1: Central Nervous System Stimulants and Drugs That Suppress Appetite -- Amphetamine and Amphetamine Derivates [SEDA-35, 1 -- SEDA-36, 1 -- SEDA-37, 1 -- SEDA-38, 1 -- SEDA-39, 1] -- Organs and Systems -- Cardiovascular -- Nervous System -- Gastrointestinal -- Death -- Ecstasy (3,4-Methylenedioxy-N-Methylamphetamine, MDMA) -- Organs and Systems. 
505 8 |a Pulmonary -- Liver -- Nervous System -- Death -- Methylphenidate [SEDA-35, 1 -- SEDA-36, 1 -- SEDA-37, 1 -- SEDA-38, 1 -- SEDA-39, 1] -- Organs and Systems -- Nervous System -- Hair -- Skin -- Drug-Drug Interaction -- Methylxanthines -- Caffeine [SEDA-33, 11 -- SEDA-34, 6 -- SEDA-36, 1 -- SEDA-37, 1 -- SEDA-38, 1 -- SEDA-39, 1] -- Organs and Systems -- Nervous System -- Drug-Drug Interaction -- Selective Norepinephrine Reuptake Inhibitors Atomoxetine [SEDA-36, 1 -- SEDA-37, 1 -- SEDA-38, 1 -- SEDA-39, 1] -- Organ and Systems -- Nervous System -- Drug-Drug Interactions -- Vigilance Promoting Drugs -- Modafinil and Armodafinil [SEDA-36, 1 -- SEDA-37, 1 -- SEDA-38, 1 -- SEDA-39, 1] -- Organs and Systems -- Drug-Drug Interactions -- Pitolisant -- Drugs That Suppress Appetite [SEDA-36, 1 -- SEDA-37, 1 -- SEDA-38, 1 -- SEDA-39, 1] -- Phentermine [SEDA-36, 1 -- SEDA-37, 1 -- SEDA-38, 1 -- SEDA-39, 1] -- Organs and Systems -- Renal -- Naltrexone Sustained-Release/Bupropion Sustained-Release [SEDA-37, 1] -- Organs and Systems -- Skin -- Drug-Drug Interactions -- Parasympathomimetics [SEDA-34, 9 -- SEDA-36, 1 -- SEDA-37, 1 -- SEDA-38, 1] -- Donepezil [SEDA-36, 1 -- SEDA-37, 1 -- SEDA-38, 1 -- SEDA-39, 1] -- Organ and Systems -- Cardiovascular -- Musculoskeletal -- Memantine [SEDA-34, 1 -- SEDA-39, 1] -- Organ and Systems -- Skin -- Musculoskeletal -- Rivastigmine [SEDA-36, 1 -- SEDA-37, 1 -- SEDA-38, 1 -- SEDA-39, 1] -- Organ and Systems -- Cardiovascular -- Musculoskeletal -- References -- Chapter 2: Antidepressants -- General -- Hematological -- Upper Gastrointestinal Bleeding -- Postpartum Hemorrhage -- Venous Thromboembolism -- Nervous System -- Stroke -- Seizures -- Jitteriness -- Emotional Blunting -- Cardiovascular -- Vascular Outcomes -- Acute Myocardial Infarction -- Endocrine -- Type 2 Diabetes -- Pancreatitis. 
505 8 |a Reproductive System (Pregnancy, Development and Infancy) -- Pregnancy -- Fetal Malformations -- Preeclampsia -- Persistent Pulmonary Hypertension of the Newborn -- Childhood Psychiatric Disorders -- Autism -- ADHD -- Falls and Fractures -- Sensory Systems -- Glaucoma -- Cataracts -- Selective Serotonin Reuptake Inhibitors -- Fluoxetine -- Interstitial Lung Disease -- References -- Chapter 3: Lithium -- Introduction -- Organs and Systems -- Nervous System -- Cardiovascular -- Renal -- Endocrine -- Dermatologic -- Pregnancy -- Drug-Drug Interactions -- References -- Chapter 4: Drugs of Abuse -- Introduction -- Cannabinoids: Synthetic (Hong) -- Cardiovascular -- Respiratory -- Nervous System -- Urinary Tract -- Hepatic -- Drug-Drug Interactions -- Cannabinoids: Non-Synthetic (Hong) -- Cardiovascular -- Gastrointestinal Tract -- Mineral Balance -- Nervous System -- Drug-Drug Interactions -- Pregnancy -- Age -- Cannabinoids (Ku) -- Pharmacogenetics -- Alcohol (BABIN) -- Cardiovascular -- HEENT -- Nervous System -- Sensory Systems -- Endocrine -- Gastrointestinal -- Skin -- Musculoskeletal -- Immunologic -- Tumorigenicity -- Age -- Alcohol (Ku) -- Pharmacogenetics -- Benzodiazepines (May) -- Cardiovascular -- Oncology -- CNS -- Migraine -- Cognitive Decline -- Orthopedic -- Hepatic -- HEENT -- Sympathomimetics: Cocaine (May) -- HEENT -- Splenic -- CNS -- Thrombosis -- Sympathomimetics: Methamphetamine -- Pulmonary -- Endocrine -- Gastrointestinal -- Cathinones: Non-Synthetic -- General Information -- Khat Overdose -- Cathinones: Synthetic (Wisner, Hall) -- General Information -- Cardiovascular -- Nervous System/Psychological -- Death -- Pharmacogenetics -- Heroin (Babin) -- Cardiovascular -- Respiratory -- CNS -- Hematologic -- Musculoskeletal -- Heroin (Ku) -- Pharmacogenetics -- Prescription/Over-the-Counter Opioids and NPS (FUDIN) -- Population. 
505 8 |a Law (Regulations) -- Cardiovascular -- Endocrine -- Glucose Metabolism (Methadone) -- Glucose Metabolism (Buprenorphine) -- Testosterone -- Gastrointestinal -- HEENT -- Dental -- Eye -- Nasal -- Immunologic -- Hematologic -- Nervous System -- Serotonin Syndrome -- CNS -- Cognition -- Behavioral -- Mental Illness Associated Overdose -- Respiratory -- Renal -- NPS -- Fentanyl Analogs -- MT-45 -- U-47700 -- Opioid Withdrawal -- Symptoms and AE -- OUD Withdrawal treatment -- Abuse-Deterrent -- Tapentadol -- Buprenorphine -- NAS -- Death -- Prescription/Over-the-Counter Opioids and Fentanyl Analogs (Ku) -- Pharmacogenetics -- Conclusion (Precautionary Note to Clinicians) -- References -- Chapter 5: Hypnotics and Sedatives -- Benzodiazepines and Non-Benzodiazepine Gamma-Aminobutyric Acid (GABA) Agonists [SEDA-37, 5 -- SEDA-38, 4 -- SEDA-39, 5] -- Review -- Musculoskeletal System -- Infection Risk -- Benzodiazepines [SEDA-37, 5 -- SEDA-38, 4 -- SEDA-39, 5] -- Special Review -- Central Nervous System -- Cardiovascular System -- Respiratory System -- Immunologic System -- Prenatal Exposure -- Non-Benzodiazepine GABA Agonists [SEDA-37, 5 -- SEDA-38, 4 -- SEDA-39, 5] -- Central Nervous System -- Infection Risk -- Ketamine [SEDA-39, 5] -- Review -- Cardiovascular System -- Endocrine System -- Infant Exposure -- Drug-Drug Interaction -- Melatonin Receptor Agonists -- l-Tryptophan -- Melatonin [SEDA-37, 5] -- Orexin Receptor Antagonists -- Almorexant -- Elderly -- Filorexant -- Suvorexant -- Elderly -- Adolescents -- Propofol [SEDA-38, 4 -- SEDA-39, 5] -- Cardiovascular System -- Infection Risk -- References -- Chapter 6: Antipsychotic Drugs -- General [SEDA-35, 85 -- SEDA-36, 59 -- SEDA-37, 63 -- SEDA-38, 35 -- SEDA-39, 65] -- Comparative Studies -- Observational Studies -- Systematic Reviews -- Cardiovascular -- Ear, Nose, Throat -- Nervous System. 
505 8 |a Sensory Systems -- Endocrine -- Metabolism -- Hematologic -- Skin -- Musculoskeletal -- Urinary Tract -- Sexual Function -- Reproductive Function -- Breasts -- Immunologic -- Death -- Drug-Drug Interactions -- Diagnosis of Adverse Drug Reactions -- Individual Drugs -- Amisulpride [SEDA-36, 59 -- SEDA-37, 67 -- SEDA-38, 38 -- SEDA-39, 69] -- Controlled Studies -- Observational Studies -- Nervous System -- Psychiatric -- Urinary Tract -- Aripiprazole [SEDA-35, 96 -- SEDA-36, 59 -- SEDA-37, 68 -- SEDA-38, 38 -- SEDA-39, 69] -- Controlled Studies -- Observational Studies -- Systematic Reviews -- Cardiovascular -- Respiratory -- Nervous System -- Psychiatric -- Electrolyte Balance -- Hematologic -- Urinary Tract -- Skin -- Sweat Glands -- Musculoskeletal -- Susceptibility Factors -- Drug-Drug Interactions -- Asenapine [SEDA-37, 69 -- SEDA-38, 39 -- SEDA-39, 70] -- Controlled Studies -- Observational Studies -- Systematic Reviews -- Nervous System -- Brexpiprazole [SEDA-38, 40 -- SEDA-39, 71] -- Observational Studies -- Systematic Reviews -- Cariprazine (SEDA-38, 40 -- SEDA-39, 40) -- Observational Studies -- Chlorpromazine [SEDA-35, 85 -- SEDA-36, 59 -- SEDA-37, 69 -- SEDA-38, 40 -- SEDA-39, 71] -- Sensory Systems -- Clozapine [SEDA-35, 99 -- SEDA-36, 59 -- SEDA-37, 69 -- SEDA-38, 40 -- SEDA-39, 72] -- Observational Studies -- Systematic Reviews -- Cardiovascular -- Respiratory -- Nervous System -- Neuromuscular Function -- Eyes -- Endocrine -- Metabolic -- Hematologic -- Gastrointestinal -- Sexual Function -- Immunologic -- Body Temperature -- Second-Generation Effects -- Susceptibility Factors -- Drug-Drug Interactions -- Fluphenazine [SEDA-37, 71 -- SEDA-39, 74] -- Musculoskeletal -- Haloperidol [SEDA-35, 107 -- SEDA-36, 59 -- SEDA-37, 72 -- SEDA-38, 42 -- SEDA-39, 74] -- Systematic Reviews -- Cardiovascular System -- Nervous System -- Overdose. 
650 0 |a Drugs  |x Side effects. 
650 2 |a Drug-Related Side Effects and Adverse Reactions  |0 (DNLM)D064420 
650 6 |a M�edicaments  |x Effets secondaires.  |0 (CaQQLa)201-0002241 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a Drugs  |x Side effects  |2 fast  |0 (OCoLC)fst00898912 
700 1 |a Ray, Sidhartha D.,  |e editor. 
776 0 8 |i Print version:  |t Side effects of drugs annual. Volume 40.  |d Amsterdam, Netherlands : Elsevier, 2018  |z 9780444641199 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/bookseries/03786080/40  |z Texto completo 

Ejemplares similares